“CVS Pharmacy announced it’s pulling the heartburn medication Zantac from its shelves over a possible link to cancer. The popular over-the-counter drug and CVS’ own generic brand — ranitidine — will not be carried in the stores moving forward after trace amounts of a known carcinogen were found by health officials.
“Earlier this month, the Food and Drug Administration (FDA) said some of the pills tested contained small amounts of N-nitrosodimethylamine (NDMA).
“NDMA can be harmful in large amounts, but the levels the FDA found in preliminary tests of ranitidine “barely exceed amounts you might expect to find in common foods,” according to a statement from Dr. Janet Woodcock, research director for the agency’s Centers for Drug Evaluation and Research.”
Read more at CBS
